Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Microglial priming through the lung-brain axis: the role of air pollution-induced circulating factors.
Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology.
A Comparison of Stated Preferences for Injectable Disease-Modifying Treatments for Multiple Sclerosis: Compliant Vs. Non-Compliant Patients.
Hypoxia-inducible factor 1 in autoimmune diseases.
"Her illness is a project we can work on together": developing a collaborative family-centered intervention model for newly diagnosed multiple sclerosis.
Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.
NADPH oxidase 2 (NOX2) enzyme activation in patients with chronic inflammatory demyelinating polyneuropathy.
Imaging of Proteins in Tissue Samples Using Nanospray Desorption Electrospray Ionization Mass Spectrometry.
Fluctuating neurological symptoms in demyelinating disease mimicking an acute ischaemic stroke.
Data Quality Challenges in Systemic Lupus Erythematosus Trials: How Can This Be Optimized?
Considering depression as a consequence of activation of the inflammatory response system.
Experimental autoimmune encephalomyelitis and age-related correlations of NADPH oxidase, MMP-9, and cell adhesion molecules: The increased disease severity and blood-brain barrier permeability in middle-aged mice.
GM-CSF in Neuroinflammation: Licensing Myeloid Cells for Tissue Damage.
The hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis.
Gram-negative bacterial molecules associate with Alzheimer disease pathology.
Resveratrol Exacerbates Both Autoimmune and Viral Models of Multiple Sclerosis.
Transdermal immunotherapy: Past, present and future.
The adaptive immune response in celiac disease.
T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
Inhibitor IκBα promoter functional polymorphisms in patients with multiple sclerosis.
Viral vectors for therapy of neurologic diseases.
Hypothesis: Fingolimod explores new horizons in treatment of lymphoma.
Treatment adherence in multiple sclerosis: a survey of Belgian neurologists.
Enhancing our understanding of white matter changes in early multiple sclerosis.
Anxiety, depression and fatigue at 5-year review following CNS demyelination.

Pages